Vertex’s biggest overhang: a rival 50 times smaller
Despite another strong earnings report, analysts warned that upcoming cystic fibrosis data from Sionna Therapeutics "looms large" over Vertex.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.